Looking to learn more about outsourcing medical manufacturing? You’ve reached the right place. Watch our blog for white papers, tips, article links and other information focused on helping medical device manufacturers save time and money without cutting quality. If you’d like to learn more about Forefront Medical’s capabilities, visit our About page or our website: http://www.forefrontmedical.com/.
Intellectual property (IP) is the core of competitive advantage. When products are outsourced, the contract manufacturer performing the final assembly typically has access to the complete documentation package for the products they build. Where are the checks and balances? How can be certain your company’s IP will be protected? In this whitepaper, Forefront Medical Technology, a specialty contract manufacturer with a focus in disposable diagnostic, drug delivery systems and medical device systems, looks at four areas sourcing teams should audit in determining the ability of their contract manufacturer to support their IP protection needs.
- Company business model
- Supply chain management/documentation control practices
- Level of vertical integration
- Legal protections within the contract manufacturers headquarters’ country.
Read the full whitepaper here.
Forefront Medical Technology’s President Walter Tarca contributed a column to the June 2019 issue of Medical Product Outsourcing on Outsourcing and Trade Policies. Read the full column here.
Regulatory changes can have significant impact on product design and market competitiveness. One upcoming example of this impact is the expansion of the European Union’s (EU) list of Restricted or Hazardous Substances, commonly referred to as RoHS 3. The phthalates added to the list are driving a switch from polyvinyl chloride (PVC) to polyurethane (PU) in medical products including tubing, catheters and bags. As with other RoHS directives, regions outside the EU have followed suit in legislation that restricts these substances. And, economies of scale considerations ultimately drive medical device manufacturers to alternatives which are not restricted in any market. Forefront Medical Technology’s latest whitepaper looks at the implications of this legislation and ways a contract manufacturing partner can assist in the effort to fully evaluate the range of acceptable alternatives, the cost impact of a change, and efficient development and commercialization of products utilizing the chosen alternative materials. Read the full paper here.